TY  - CONF

T1  - PROGRESSIVE AND SUSTAINED DISEASE CONTROL IN PATIENTS WITH ATOPIC DERMATITIS (AD) AGED 12-17 YEARS TREATED WITH TRALOKINUMAB FOR 52 WEEKS

JO  - ACTA DERMATO-VENEREOLOGICA

PY  - 2023/01/01

AU  - Wollenberg A

AU  - Cork MJ

AU  - Hong HC-H

AU  - Taveira CM

AU  - Kurbasic A

AU  - Vacko E

AU  - Paller AS

ED  - 

VL  - 103

SP  - 30

EP  - 30

Y2  - 2024/12/22

ER  -